With trailing P/E negative and no forward estimates shown, the market appears to be pricing QTRX primarily on revenue and book value rather than on earnings power. The P/B of 0.42 against a shrinking equity base suggests investors are discounting the carrying value of assets, which may reflect skepticism about the goodwill-heavy balance sheet. Investors should monitor whether the sub-1x sales multiple reflects a durable discount or a temporary dislocation tied to the unproven path to breakeven.

The gross margin compression of roughly 26 percentage points is the more concerning trend, since it suggests pricing pressure, product mix shift, or rising cost of revenue rather than purely operating deleverage. Operating expenses appear to be growing faster than gross profit, which implies the business is not yet at a scale where fixed costs are absorbed. This pattern warrants further investigation into whether the margin decline is structural or tied to acquisition-related integration.

Interest coverage and EBITDA-based leverage cannot be computed because EBITDA and interest expense are not positive in the supplied data, so debt service capacity is data unavailable. The stable absolute debt level alongside falling equity suggests the leverage picture is deteriorating in relative terms even though the headline ratio looks conservative. Investors should monitor whether continued operating losses erode the equity cushion further.

A current ratio above 3 remains comfortable on paper, but the steep decline over ten quarters reflects both cash deployment into acquisitions and a shrinking working capital base. Inventory dependence appears modest given the quick ratio tracks closely to the current ratio, though the 222-day DIO in 2026Q2 suggests slow-moving inventory that warrants monitoring. Under severe stress, the liquidity position would depend on how quickly operating losses are curtailed relative to the remaining cash balance.